Cost of Insulin Doubled as Usage Stayed Flat, Says HCCI

Drug Industry Daily
Insulin costs nearly doubled from 2012 to 2016, even as usage remained stable, according to a new analysis from the Health Care Costs Institute (HCCI) — a non-profit funded in part by Aetna, Humana, Kaiser Permanente and UnitedHealthcare.

To View This Article:


Subscribe To Drug Industry Daily